Oncosil Medical Says A$8.7M Capital Raise At Issue Price A$0.003 Per Share

Published on 05/25/2025 at 21:32

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about OncoSil Medical Limited

ASX Biggest Losers	Jul. 10	MT
OncoSil Medical Completes Patient Recruitment for Pancreatic Cancer Study	Jul. 03	MT
Oncosil Medical Says A$8.7M Capital Raise At Issue Price A$0.003 Per Share	May. 25	RE
Oncosil Medical Seeks Trading Halt	May. 21	RE
OncoSil Medical Said Analysis Shows Better Survival for Pancreatic Cancer Patients Treated with Therapy Device	May. 07	MT
OncoSil Medical Limited Announces Changes to Company Secretary, Effective April 1, 2025	Mar. 31	CI
Oncosil Medical Appoints Shelley Steyn As CFO	Mar. 17	RE
ASX Small-Cap Stocks to Watch	Mar. 17	MT
Oncosil Announces CFO Changes	Mar. 17	CI
Oncosil Announces Resignation of Christian Dal Cin as Company Secretary, Effective Date Is March 31, 2025	Mar. 17	CI
OncoSil Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2024	Feb. 25	CI
OncoSil Medical Says 120 German Hospitals Secure Authorization to Negotiate Fee for Cancer Treatment Device; Shares Surge 40%	Feb. 03	MT
OncoSil Medical Receives Medical Device Regulation Certification; Shares Surge 20%	Jan. 28	MT
OncoSil Medical Limited Announces the Appointment of Lel Smits as a Non- Executive Director to the Board	Jan. 14	CI
ASX Biggest Losers	Jan. 08	MT
ASX Biggest Gainers	Jan. 06	MT
ASX Biggest Gainers	Jan. 01	MT
OncoSil Medical Randomizes First South Australia Patient in Pancreatic Cancer Clinical Trial; Shares Up 17%	Dec. 30	MT
OncoSil Medical Signs Exclusive Distribution Agreements in Nordics Region, Egypt	Nov. 17	MT
OncoSil Medical Secures UK Conformity Assessed Renewal Certificates for Cancer Treatment Device; Shares Up 8%	24-10-20	MT
OncoSil Medical Secures Distribution Deal for Pancreatic Cancer Therapy in Middle East; Shares Drop 7%	24-10-06	MT
Peter Hall Elects Not to Join Oncosil Medical Limited's Board	24-09-29	CI
OncoSil Medical Achieves Milestones in Two Pancreatic Cancer Trials; Shares Up 8%	24-09-26	MT
OncoSil Medical Limited Appoints Peter Hall as Non-Executive Director	24-08-30	CI
OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2024	24-08-29	CI